How many clinical trials are tracked of selpercatinib?

15 trials are tracked, 0 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Genetics & Precision Medicine Pulmonology & Critical Care Anesthesiology & Pain Medicine Nephrology Physical Medicine & Rehab Emergency Medicine Urology Hematology Ophthalmology Dermatology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

selpercatinib

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of selpercatinib

15 trials tracked of selpercatinib.

15Trials tracked

0Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 1 15

Phase 1 A Study of Selpercatinib (LY3527723) in Healthy Participants Completed
Phase 1 A Study of Effect of Selpercatinib (LY3527723) on Corrected QT (QTc) Interval in Healthy Participants Completed
Phase 1 A Study of the Effect of Food on Selpercatinib (LY3527723) in Healthy Participants Completed
Phase 1 A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants Completed
Phase 1 A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal Function Completed
Phase 1 A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants Completed

Show 9 more trials

Phase 1 A Study of Absorption, Metabolism, Excretion, and Absolute Bioavailability of Carbon-14-Labelled [14C] Selpercatinib (LY3527723) in Healthy Male Participants Completed
Phase 1 A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy Participants Completed
Phase 1 A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants Completed
Phase 1 A Study of Effects of Selpercatinib in Hepatically Impaired Participants and Healthy Participants Completed
Phase 1 A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy Participants Completed
Phase 1 A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy Participants Completed
Phase 1 Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants Completed
Phase 1 A Relative Bioavailability Study of Selpercatinib (LY3527723) in Healthy Participants Completed
Phase 1 A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Participants Completed

Showing the 15 most-cited and recently-updated of 15 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.